Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

Novocure Limited · 10-Q · Q2 FY2026 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

There have been no material changes from the information disclosed in our 2025 10-K.